Pular para o conteúdo
Case de Valor
Voltar para Stocks
BDX

BDX

Becton, Dickinson and Company

NYSE / NasdaqSaúde
Fechamento (EOD)
US$ 198,91-0,75%

Indicadores principais

Valuation

Valor de Mercado

US$ 54,2 Bi

Da companhia, em dólares

Valuation

P/L

46,3×

Preço / Lucro

Valuation

P/L Futuro

15,0×

Sobre o lucro projetado pelo consenso

Valuation

P/VP

2,2×

Preço / Valor Patr.

Rentabilidade

Margem Líquida

4,2%

Parcela da receita convertida em lucro líquido.

Rentabilidade

ROE

6,6%

Retorno s/ patrimônio

Rentabilidade

Dividend Yield

2,1%

Último provento anualizado

Setor

Saúde

Medical Instruments & Supplies

Histórico de Preço

US$ 198,91

Performance

1 dia

—

1 sem

—

1 mês

—

3 meses

—

6 meses

—

1 ano

—

5 anos

—

Dados gerais

SetorSaúde
IndústriaMedical Instruments & Supplies
PaísEstados Unidos
Funcionários72.000
MoedaUSD

Descrição

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Cotação com possível atraso. Conteúdo de caráter informativo e educacional. Não constitui recomendação de compra, venda ou manutenção de ativos.